NCT04387981View on ClinicalTrials.gov

Mass Balance Study of [14C]-Orvepitant Oral Solution in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

June 28, 2020

Study Completion Date

June 28, 2020

Conditions
Healthy
Interventions
DRUG

[14C]-orvepitant

Oral solution of \[14C\]-orvepitant

Trial Locations (1)

Unknown

Quotient Sciences, Nottingham

Sponsors
All Listed Sponsors
lead

Nerre Therapeutics Ltd.

INDUSTRY

NCT04387981 - Mass Balance Study of [14C]-Orvepitant Oral Solution in Healthy Male Subjects | Biotech Hunter | Biotech Hunter